Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer and seller of bio pharmaceutical products. The company is engaged in researching, developing and manufacturing drugs, medical supplies and other medical equipment.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
IDT Biologika
Primary Office
  • 1405 Research Boulevard
  • Rockville, MD 20850
  • United States

Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)‘s full profile, request access.

Request full access to PitchBook

Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)‘s full profile, request access.

Request full access to PitchBook